Inmune Bio, Inc.

INMBNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$50,000

▲ 257.1% YoY

Net Income

-$45.9M

▼ 9.2% YoY

EPS

$-1.86

▲ 11.8% YoY

Cash

$24.8M

▲ 18.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.